SULFONAMIDE, INHIBITORI AI ASPARTIL PROTEAZEI HIV, COMPOZIŢII FARMACEUTICE CARE ÎI CONŢIN ŞI METODĂ DE TRATAMENT
Prețul nu e vizibil în cazul acestui pachet
Interes:
Atribuire
Informații publicare:
Nr.: RO118747
Data: 30.10.2003
Inventator(i):
TUNG ROGER D [US]
MURCKO MARK A [US]
BHIDETTI GOVINDA RAO [US]
Aplicant(i):
VERTEX PHARMA [US]
Clasificare:
Clasificare internationala (IPC):
A61K31/16; A61K31/165; A61K31/17; A61K31/18; A61K31/255; A61K31/27; A61K31/325; A61K31/34; A61K31/341; A61K31/343; A61K31/35; A61K31/40; A61K31/4015; A61K31/403; A61K31/404; A61K31/41; A61K31/415; A61K31/42; A61K31/421; A61K31/4245; A61K31/425; A61K31/426; A61K31/44; A61K31/4402; A61K31/4418; A61K31/4433; A61K31/445; A61K31/47; A61K31/495; A61K31/496; A61K31/505; A61K31/535; A61K31/5375; A61K31/5377; A61K31/63; A61K38/55; A61P31/12; A61P31/18; C07C307/02; C07C307/06; C07C311/13; C07C311/18; C07C311/29; C07C311/39; C07C311/41; C07C311/46; C07D207/12; C07D207/26; C07D207/27; C07D207/28; C07D209/08; C07D209/10; C07D213/30; C07D215/48; C07D231/14; C07D239/22; C07D239/54; C07D263/24; C07D271/08; C07D277/20; C07D277/36; C07D295/12; C07D305/12; C07D307/12; C07D307/14; C07D307/20; C07D307/52; C07D307/64; C07D307/79; C07D403/12; C07D405/12; C07D409/12; C07D409/14; C07D413/12; C07D413/14; C07D417/12; C07D419/14; C07G99/00; C07K5/078; G01N33/53; G01N33/569; A61K38/00; C07D311/42
Clasificare comuna (CPC):
A61P31/12 (EP); A61P31/18 (EP); C07C307/06 (EP, US); C07C311/13 (EP, US); C07C311/18 (EP, US); C07C311/29 (EP, US); C07C311/39 (EP, US); C07C311/46 (EP, US); C07D207/26 (EP, US); C07D209/08 (EP, US); C07D213/30 (EP, US); C07D213/78 (EP, US); C07D215/38 (EP, US); C07D215/48 (EP, US); C07D231/14 (EP, US); C07D239/22 (EP, US); C07D263/24 (EP, US); C07D271/08 (EP, US); C07D277/36 (EP, US); C07D307/12 (EP, US); C07D307/20 (EP, US); C07D403/12 (EP, US); C07D405/12 (EP, US); C07D409/12 (EP, US); C07D409/14 (EP, US); C07D413/12 (EP, US); C07D413/14 (EP, US); C07D417/12 (EP, US); C07K5/06139 (EP, US); A61K38/00 (EP, US); C07C2601/02 (EP, US); C07C2601/08 (EP, US); C07C2601/14 (EP, US)
Informații aplicație:
Nr.: RO19950000479
Data:
07.09.1993
Număr/numere prioritar(e):
US19920941982
08.09.1992
; WO1993US08458
07.09.1993
Brevete asociate:
AP390; ATE178598; ATE241602; AU4852093; AU691160; BG62488; BG99540; BR1100824; CA2143208; CN1061339; CN1087347; CO4870779; CY2164; CZ289475; CZ58795; DE10199024; DE69324369; DE69333012; DK0659181; DK0885887; EP0659181; EP0885887; ES2131589; ES2200243; FI120685; FI951059; GEP20012579; GR3030719; HK1012631; HK1023561; HU228198; HUT71892; IL106927; IS2334; IS4068; JP3012002; JPH08501299; KR100262056; LT3302; LTIP917; LU90736; MXPA03010538; MY142901; NL300039; NO2001012; NO303444; NO950876; NZ256238; NZ314376; PH31251; PL185635; PL307858; PT885887; RU2135496; RU95109928; SG43862; SK281360; SK29395; TW254927; UA44694; US2003069222; US2006189810; US2008293727; US2010210603; US5585397; US5856353; US6372778; US7608632; WO9405639
Descriere:
Prezenta invenţie se referă la sulfonamide, inhibitori ai aspartil proteazei HIV, la compoziţiile farmaceutice care îi conţin şi la metoda de tratament. Sulfonamidele conform invenţiei sunt utilizate ca agenţi antivirali faţă de HIV-1 şi HIV-2, fiind folositori în tratamentul infecţiei HIV la un mamifer. ŕ
